Notably, PC patients and CC patients with higher ZCCHC4 expression demonstrated shorter overall survival (Fig. 1i, j), while LC patients with higher ZCCHC4 expression did not show survival disadvantage (Fig. 1k). This evidence concerns the gene ZCCHC4 and pachyonychia congenita.